advertisement

Topcon

Marchini G 10

Showing records 1 to 10 | Display all abstracts from Marchini G

100330 Glaucoma surgery during the first year of the COVID-19 pandemic
Longo R
International Ophthalmology 2022; 42: 2881-2887
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Oddone F; Scorcia V
Clinical Ophthalmology 2022; 16: 1707-1719
100330 Glaucoma surgery during the first year of the COVID-19 pandemic
Franzolin E
International Ophthalmology 2022; 42: 2881-2887
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Iester M
Clinical Ophthalmology 2022; 16: 1707-1719
100330 Glaucoma surgery during the first year of the COVID-19 pandemic
Pedrotti E
International Ophthalmology 2022; 42: 2881-2887
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Sisto D
Clinical Ophthalmology 2022; 16: 1707-1719
100330 Glaucoma surgery during the first year of the COVID-19 pandemic
Fasolo A; Bonacci E
International Ophthalmology 2022; 42: 2881-2887
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
De Cilla S; Bettin P
Clinical Ophthalmology 2022; 16: 1707-1719
100330 Glaucoma surgery during the first year of the COVID-19 pandemic
Marchini G
International Ophthalmology 2022; 42: 2881-2887
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Cagini C; Figus M; Marchini G; Rossetti L; Rossi G; Salgarello T; Scuderi GL; Staurenghi G;
Clinical Ophthalmology 2022; 16: 1707-1719

Issue 23-1

Change Issue


advertisement

Oculus